Scholarly article on Androst-16-en-3-one 32925-78-3 from Journal of Agricultural and Food Chemistry p. 1241,1242,1243

DOI: 10.1021/jf60214a033

Source and publish data:

Journal of Agricultural and Food Chemistry p. 1241,1242,1243 (1977)

Update date:2022-08-05

Topics:

Authors:

Thompson

Pearson Pearson

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/jf60214a033

Full text of DOI:10.1021/jf60214a033

Products guided by the article

Product name:Androst-16-en-3-one

Cas No:32925-78-3

R&D Labs maybe for 32925-78-3

SNC | GOOD FORTUNE

Contact:0086-22-2822 1962 / 2822 1963

Address:B-808, No. 1, North-South Street, Hexi District,
Shandong Jincheng Zhonghua Bio-pharmaceutical Co.,Ltd

Contact:+86-533-5415882

Address:Zichuan Economic Development Zone,Zibo City,Shandong Province,China
HENAN NEW BLUE CHEMICAL CO.,LTD

website:http://www.newbluechem.com

Contact:86-371-55170693/55170694

Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Hangzhou Dingyan Chem Co., Ltd

website:http://www.dingyanchem.com

Contact:86-571-87157530

Address:RM.1118,NO.1 Building, Baiyun Tower,Jianggan Area, Hangzhou city, China,310004
Hangzhou Share Chemical Co., Ltd(expird)

Contact:+86-57187093700

Address:Hang Xing Road

Relevant to this article

Doi:10.1007/BF00567852
()
Synthesis and anticancer activity of novel rapamycin C-28 containing triazole moiety compounds

Doi:10.1002/ardp.201800123
(2018)
Synthesis of a Tri-, a Penta-, and a Hepta-saccharide Containing Terminal N-Acetyl-β-D-lactosaminyl Residues, Part of the 'Complex-type' Carbohydrate Moiety of Glycoproteins

Doi:10.1039/P19810002070
(1981)
Independent generation and characterization of a C2′-oxidized abasic site in chemically synthesized oligonucleotides

Doi:10.1021/jo049033d
(2004)
Thermolysis of dimethyl 3,3-(2,2′-biphenylyl)-3H-pyrazole-4,5-dicarboxylate

Doi:10.1021/jo00322a042
(1981)
Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation.

Doi:10.1021/jm049752k
(2004)

Article Doi

DOI: 10.1021/jf60214a033